中文版    |    English
  Tel +86-571-88737065   QQ Online

Company News

- 2019-07-05

FDA Approves Xpovio

  FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

- 2019-07-04

New synthetic technology for medicines and fine chemicals

  A University of Tokyo research group has succeeded in synthesizing (R)- and (S)-rolipram, the active component of